GENB
Generate Biomedicines, Inc.
Next earnings ≈ Aug 6, 2026 · est. from filing cadence
Last earnings -11.2% on 2026-05-07
$16.42
▲ +1.17%$16.42▲ +2.63%
over 1Y
L $11.21EODHDH $16.42
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+1.2%
1W+13.3%
1M+23.1%
3M+27.8%
YTD+2.6%
1Y+2.6%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 11 analysts
Buy
Mixed signals in the latest filings.
Generate Biomedicines, Inc. shows limited reported revenue.
Sources: SEC EDGAR (CIK 0002100782, latest 10-Q filed 2026-05-07) · EODHD · as of 6/26/2026, 1:54:29 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.